Literature DB >> 11817715

Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: an unusual clinical coexistence.

G Mazziotti1, M Rotondi, G Manganella, R Franco, V Colantuoni, G Amato, C Carella.   

Abstract

We describe the unusual case of a Caucasian woman who had a diagnosis of medullary thyroid cancer and papillary microcarcinoma 5 years after a diagnosis of Graves' disease. The patient came to our observation for recurrence of hyperthyroidism. An ultrasound scan revealed diffuse thyroid enlargement with a nodule, recently increased in size. The serum CT and carcinoembrional antigen were elevated, and the fine-needle aspiration cytology with immunocytochemical analysis for CT was suggestive for medullary thyroid carcinoma. The nodular lesion showed intense 111In-pentetreotide uptake, whereas total body scintigraphy with the same tracer and with Thallium-201, 99mTc (V) dimercaptosuccinic acid was negative for lymph node and distant metastasis. The histological examination of thyroidectomy specimens confirmed the diagnosis of medullary thyroid cancer, showing a lymphocytic intratumoral infiltration. The histological analysis of the controlateral lobe showed an occult papillary microcarcinoma. Medullary thyroid carcinoma and papillary microcarcinoma showed intense staining with policlonal anti-RET antibodies, although genetic analysis was negative for RET mutations most frequently involved in familial and sporadic medullary thyroid carcinomas. Possible implications about the coexistence of the 3 thyroid diseases are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11817715     DOI: 10.1007/bf03343948

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

1.  Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis.

Authors:  L Vini; S Hyer; B Pratt; C Harmer
Journal:  Postgrad Med J       Date:  1999-03       Impact factor: 2.401

2.  Medullary thyroid carcinoma in Graves' disease.

Authors:  M Brändle; R L Galeazzi; P A Diener; C Schmid
Journal:  Clin Endocrinol (Oxf)       Date:  1999-04       Impact factor: 3.478

3.  Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma.

Authors:  K Kashima; S Yokoyama; S Noguchi; N Murakami; H Yamashita; S Watanabe; S Uchino; M Toda; A Sasaki; T Daa; I Nakayama
Journal:  Thyroid       Date:  1998-03       Impact factor: 6.568

4.  Prognostic impact of thyroid lymphocytic infiltration in patients with medullary thyroid carcinoma.

Authors:  L Scopsi; P Collini; G Sampietro; P Boracchi; S Pilotti
Journal:  Thyroid       Date:  1996-12       Impact factor: 6.568

5.  Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.

Authors:  M F Saad; H A Fritsche; N A Samaan
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

6.  Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases.

Authors:  N Beressi; J M Campos; J P Beressi; B Franc; P Niccoli-Sire; B Conte-Devolx; A Murat; P Caron; L Baldet; J L Kraimps; R Cohen; J C Bigorgne; O Chabre; P Lecomte; E Modigliani
Journal:  Thyroid       Date:  1998-11       Impact factor: 6.568

7.  The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland.

Authors:  S Matsubayashi; K Kawai; Y Matsumoto; T Mukuta; T Morita; K Hirai; F Matsuzuka; K Kakudoh; K Kuma; H Tamai
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

8.  Thyroid stimulating immunoglobulins, like thyrotropin activate both the cyclic AMP and the PIP2 cascades in CHO cells expressing the TSH receptor.

Authors:  J Van Sande; C Lejeune; M Ludgate; D S Munro; G Vassart; J E Dumont; J Mockel
Journal:  Mol Cell Endocrinol       Date:  1992-10       Impact factor: 4.102

9.  Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma.

Authors:  C Eng; L M Mulligan; D P Smith; C S Healey; A Frilling; F Raue; H P Neumann; R Pfragner; A Behmel; M J Lorenzo
Journal:  Genes Chromosomes Cancer       Date:  1995-03       Impact factor: 5.006

10.  Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.

Authors:  C Romei; R Elisei; A Pinchera; I Ceccherini; E Molinaro; F Mancusi; E Martino; G Romeo; F Pacini
Journal:  J Clin Endocrinol Metab       Date:  1996-04       Impact factor: 5.958

View more
  5 in total

Review 1.  Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature.

Authors:  Benedetta Fibbi; Pamela Pinzani; Francesca Salvianti; Matteo Rossi; Luisa Petrone; Maria Laura De Feo; Roberto Panconesi; Vania Vezzosi; Simonetta Bianchi; Gabriele Simontacchi; Monica Mangoni; Maurizio Pertici; Gianni Forti; Cinzia Pupilli
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

2.  Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland.

Authors:  R Ciampi; C Romei; L Pieruzzi; A Tacito; E Molinaro; L Agate; V Bottici; F Casella; C Ugolini; G Materazzi; F Basolo; R Elisei
Journal:  J Endocrinol Invest       Date:  2016-08-17       Impact factor: 4.256

3.  Nodular Graves' disease with medullary thyroid cancer.

Authors:  Shoukat Hussain Khan; Tanveer Ahmed Rather; Rumana Makhdoomi; Dharmender Malik
Journal:  Indian J Nucl Med       Date:  2015 Oct-Dec

4.  Simultaneous medullary and papillary thyroid cancer: two case reports.

Authors:  Gianlorenzo Dionigi; Patrizia Castano; Valentina Bertolini; Luigi Boni; Francesca Rovera; Maria Laura Tanda; Carlo Capella; Luigi Bartalena; Renzo Dionigi
Journal:  J Med Case Rep       Date:  2007-11-12

5.  A Rare Coexistence of Medullary Thyroid Cancer with Graves Disease: A Case Report and Systematic Review of the Literature.

Authors:  Konstantinos Sapalidis; Anastasios Papanastasiou; Nikolaos Michalopoulos; Stylianos Mantalovas; Dimitrios Giannakidis; Georgios D Koimtzis; Maria Florou; Christos Poulios; Niki Mantha; Isaak I Kesisoglou
Journal:  Am J Case Rep       Date:  2019-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.